Ehud Grenadier, MD

Original Contribution

The Impact of GP IIb/IIIa Inhibitors During Primary Percutaneous Coronary Intervention in Acute Myocardial Infarction Patients

08/01/2008

Ehud Grenadier , MD;

Michael Kapeliovich , MD;

Monther Boulos , MD;

Walter Markiewicz , MD;

Haim Hammerman , MD;

Shahar Lavi , MD, PhD;

Doron Aronson , MD;

Luis Gruberg , MD;

Rafael Beyar , MD, DSc, MPH;

In the last decade, primary percutaneous coronary intervention (PCI) has emerged as a superior strategy compared to thrombolytic therapy for coronary reperfusion in acute myocardial infarction patients.1–4 It is associated with lower...

In the last decade, primary...

08/01/2008

Journal of Invasive Cardiology

Original Contribution

Comparison of Two Platelet Glycoprotein IIb/IIIa Inhibitors, Eptifibatide and Abciximab: Outcomes, Complications and Thrombocyto

08/01/2008

Rafael Beyar , MD, DSc, MPH;

Ehud Grenadier , MD;

Walter Markiewicz , MD;

Haim Hammerman , MD;

Monther Boulus , MD;

Alexander Goldberg , MD;

Luis Gruberg , MD;

Doron Aronson , MD;

Mahmoud Suleiman , MD;

Majdi Halabi , MD;

The development of platelet glycoprotein (GP) IIb/IIIa receptor inhibitors has been a major advance in reducing ischemic complications among a broad spectrum of patients undergoing percutaneous coronary intervention (PCI).1–9 Currently, three...

The development of platelet...

08/01/2008

Journal of Invasive Cardiology

Percutaneous Coronary Interventions in Diabetic Patients: Is Complete Revascularization Important?

08/01/2008

Luis Gruberg , MD;

Ariel Roguin , MD, PhD;

Rafael Beyar , MD, DSc, MPH;

Ehud Grenadier , MD;

Chandrashekhar V. Patil , MD;

Michael Kapeliovich , MD;

Sirouch Petcherski , MD;

Monther Boulos , MD;

Shlomo Amikam , MD;

Shai Linn , MD;

Walter Markiewicz , MD;

Eugenia Nikolsky , MD, PhD;

ABSTRACT: Background. The long-term prognosis of diabetic patients with multivessel coronary artery disease (CAD) treated by surgical or percutaneous coronary revascularization is significantly worse as compared to non-diabetics. Lower rates...

ABSTRACT: Background. The...

08/01/2008

Journal of Invasive Cardiology

Traditional Versus Automated Injection Contrast System in Diagnostic and Percutaneous Coronary Interventional Procedures: Comp

08/01/2008

Rafael Beyar , MD, DSc, MPH;

Ehud Grenadier , MD;

Shlomo Amikam , MD;

Walter Markiewicz , MD;

Eugenia Nikolsky , MD, PhD;

Monther Boulus , MD;

Ganeshkumar Anne , MD;

Akiva Huber ;

Luis Gruberg , MD;

Contrast-induced nephropathy is a frequent cause of hospital-acquired acute or chronic renal insufficiency in patients undergoing cardiac catheterization.1,2 The increasingly frequent use of contrast-enhancing imaging for both diagnosis and...

Contrast-induced nephropathy is...

08/01/2008

Journal of Invasive Cardiology

Commentary

Pushing the Limits: Is there an Optimal Therapy for Very Small Vessels?

08/01/2008

Ariel Roguin , MD, PhD;

Ehud Grenadier , MD;

Stent placement in coronary arteries larger than 3 mm in diameter has been proven to be superior to conventional balloon angioplasty (PTCA) in reducing the risk of restenosis and major adverse cardiac events (MACE). Subsequent improvements in...

Stent placement in coronary...

08/01/2008

Journal of Invasive Cardiology

Original Contribution

Five-Year Clinical Follow Up after Intracoronary Radiation for the Prevention of In-Stent Restenosis

08/01/2008

Eugenia Nikolsky , MD, PhD;

Arthur Kerner , MD;

Luis Gruberg , MD;

Mahmoud Sileiman , MD;

Monther Boulus , MD;

Robert Caiati , MD;

Doron Aronson , MD;

Sirush Petchersky , MD;

Rafael Beyar , MD, DSc, MPH;

Ehud Grenadier , MD;

Walter Markiewicz , MD;

Intracoronary radiation therapy (IRT), utilizing both gamma- and beta-emitting radiation sources, was until recently the only effective method for the prevention of recurrent in-stent restenosis (ISR) and the need for additional...

Intracoronary radiation therapy...

08/01/2008

Journal of Invasive Cardiology

Original Contribution

Glycoprotein IIb/IIIa Inhibitors during Rescue Percutaneous Coronary Intervention in Acute Myocardial Infarction

08/01/2008

Michael Kapeliovich , MD;

Shlomo Amikam , MD;

Walter Markiewicz , MD;

Haim Hammerman , MD;

Mahmoud Sileiman , MD;

Monther Boulus , MD;

Rafael Beyar , MD, DSc, MPH;

Luis Gruberg , MD;

Ehud Grenadier , MD;

Fibrinolytic therapy for acute myocardial infarction, even with the most efficient regimens available, is fraught with a substantial proportion of failures to re-establish normal blood flow in the occluded vessel.1,2 Failure to achieve prompt...

Fibrinolytic therapy for acute...

08/01/2008

Journal of Invasive Cardiology